SILK - Silk Road Medical GAAP EPS of -$0.44 beats by $0.02 revenue of $33.17M beats by $2.14M
- Silk Road Medical press release ( NASDAQ: SILK ): Q2 GAAP EPS of -$0.44 beats by $0.02 .
- Revenue of $33.17M (+25.4% Y/Y) beats by $2.14M .
- Silk Road Medical projects revenue for the full year 2022 to range from $128 million to $133 million, which represents 26% to 31% growth over the company’s prior year revenue.
For further details see:
Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M